October 01, 2021
4 min watch
Save
VIDEO: Presentations in immunotherapy prevail at World Conference on Lung Cancer
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Upal Basu Roy, PhD, MPH, spoke with Healio about “fantastic presentations” from this year’s International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Getting more specific, Roy, executive director of research at LUNGevity Foundation, highlighted immunotherapy as a main theme of many presentations at the conference.
“What I took away from this year’s meeting was pushing the needle to make sure that we can use immunotherapy in settings that we have not used it before,” he said.
Reference:
- Johnson ML, et al. Plenary PL02.01. Presented at: International Association for the Study of Lung Cancer World Conference on Lung Cancer (virtual meeting); Sept. 8-14, 2021.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Roy reports receiving research grants to his institution from Amgen, Astra Zeneca, Blueprint Medicine, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, G1 Therapeutics, Jazz Pharmaceuticals, Merck and Takeda..
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.